Evidence map›Paper›PMID 19003592›Full record

ArticleJournal of neurovirology2008

Mechanisms of minocycline-induced suppression of simian immunodeficiency virus encephalitis: inhibition of apoptosis signal-regulating kinase 1.

Susan C Follstaedt, Sheila A Barber, M Christine Zink

Open access · greenAbstract read
In one paragraph

Article in Journal of neurovirology, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
1.2field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 34 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. The nNOS-p38MAPK pathway is mediated by NOS1AP during neuronal death.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2013
    Article
  14. Minocycline: far beyond an antibiotic.British journal of pharmacology · 2013
    Review
  15. Early minocycline treatment prevents a decrease in striatal dopamine in an SIV model of HIV-associated neurological disease.Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology · 2012
    Article
  16. Review
  17. Mitogen-activated protein kinase p38 in HIV infection and associated brain injury.Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology · 2011
    Review
  18. Article
  19. Use of minocycline in viral infections.The Indian journal of medical research · 2011
    Review
  20. HIV-associated neurocognitive disorder: pathogenesis and therapeutic opportunities.Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology · 2010
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 1 country.

Susan C FollstaedtDepartment of Molecular and Comparative Pathobiology, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205, USA.
Sheila A Barber
M Christine Zink
Booz Allen Hamilton (United States) · USJohns Hopkins Medicine · USJohns Hopkins University · US

Funding

Project 4: Intracellular mechanism of virus persistence in astrocytes/macrophagesP01MH070306 · NIMH · JOHNS HOPKINS UNIVERSITY · PI CLEMENTS, JANICE E · 2004 to 2015
$16.0M
Minocycline Inhibits Immune Reactivation of CNS SIVR01NS055648 · NINDS · JOHNS HOPKINS UNIVERSITY · PI CLEMENTS, JANICE E · 2007 to 2011
$3.2M
Neuroprotective Effects of Minocycline in Lentiviral InfR01MH069116 · NIMH · JOHNS HOPKINS UNIVERSITY · PI ZINK, M CHRISTINE · 2004 to 2008
$2.9M
Antiretroviral Therapy and SIV EncephalitisR01NS044815 · NINDS · JOHNS HOPKINS UNIVERSITY · PI ZINK, M CHRISTINE · 2002 to 2005
$2.0M
NIMH NIH HHS MH069116NIMH NIH HHS MH070306NIMH NIH HHS P01 MH070306NIMH NIH HHS R01 MH069116NINDS NIH HHS NS44815NINDS NIH HHS NS55648NINDS NIH HHS R01 NS044815NINDS NIH HHS R01 NS055648
6 · The paper itself

Abstract

Human immunodeficiency virus (HIV) infection of the central nervous system (CNS) can lead to cognitive dysfunction, even in individuals treated with highly active antiretroviral therapy. Using an established simian immunodeficiency virus (SIV)/macaque model of HIV CNS disease, we previously reported that infection shifts the balance of activation of mitogen-activated protein kinase (MAPK) signaling pathways in the brain, resulting in increased activation of the neurodegenerative MAPKs p38 and JNK. Minocycline treatment of SIV-infected macaques reduced the incidence and severity of SIV encephalitis in this model, and suppressed the activation of p38 in the brain. The purpose of this study was to further examine the effects of minocycline on neurodegenerative MAPK signaling. We first demonstrated that minocycline also decreases JNK activation in the brain and levels of the inflammatory mediator nitric oxide (NO). We next used NO to activate these MAPK pathways in vitro, and demonstrated that minocycline suppresses p38 and c-Jun N-terminal kinase (JNK) activation by reducing intracellular levels, and hence, activation of apoptosis signal-regulating kinase 1 (ASK1), a MAPK kinase capable of selectively activating both pathways. We then demonstrated that ASK1 activation in the brain during SIV infection is suppressed by minocycline. By suppressing p38 and JNK activation pathways, which are important for the production of and responses to inflammatory mediators, minocycline may interrupt the vicious cycle of inflammation that both results from, and promotes, virus replication in SIV and HIV CNS disease.

Indexed as

AnimalsBrainDose-Response Relationship, DrugEncephalitisEnzyme ActivationFemaleHumansJNK Mitogen-Activated Protein KinasesMacacaMaleMAP Kinase Kinase Kinase 5MinocyclineNeurotransmitter AgentsNitric Oxidep38 Mitogen-Activated Protein KinasesSignal TransductionJNK Mitogen-Activated Protein KinasesMAP Kinase Kinase Kinase 5MinocyclineNeurotransmitter AgentsNitric Oxidep38 Mitogen-Activated Protein Kinases

Identifiers

PMID19003592
PMCPMC2627770
OpenAlexW2028850032

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.